Cargando…
JS-K, a Nitric Oxide Prodrug, Has Enhanced Cytotoxicity in Colon Cancer Cells with Knockdown of Thioredoxin Reductase 1
BACKGROUND: The selenoenzyme thioredoxin reductase 1 has a complex role relating to cell growth. It is induced as a component of the cellular response to potentially mutagenic oxidants, but also appears to provide growth advantages to transformed cells by inhibiting apoptosis. In addition, selenocys...
Autores principales: | Edes, Kornelia, Cassidy, Pamela, Shami, Paul J., Moos, Philip J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2808390/ https://www.ncbi.nlm.nih.gov/pubmed/20098717 http://dx.doi.org/10.1371/journal.pone.0008786 |
Ejemplares similares
-
Role of human glutathione transferases in biotransformation of the nitric oxide prodrug JS-K
por: Sjödin, Birgitta, et al.
Publicado: (2021) -
MITF Is Regulated by Redox Signals Controlled by the Selenoprotein Thioredoxin Reductase 1
por: Kline, Chelsey D., et al.
Publicado: (2022) -
Cytotoxic and radiosensitising effects of a novel thioredoxin reductase inhibitor in breast cancer
por: Abdullah, Nurul A, et al.
Publicado: (2021) -
Cytotoxic and Radiosensitising Effects of a Novel Thioredoxin Reductase Inhibitor in Brain Cancers
por: Yao, Anqi, et al.
Publicado: (2022) -
TIMP-2 mediates the anti-invasive effects of the nitric oxide-releasing prodrug JS-K in breast cancer cells
por: Simeone, Ann-Marie, et al.
Publicado: (2008)